Prix YiChang HEC ChangJiang Pharmaceutical Co Ltd (01558.HK)

Yichang HEC Changjiang Pharmaceutical Co. Ltd. a PRC pharmaceutical manufacturing company that focuses on the development, manufacturing and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company is headquartered in Yichang, Guangdong and currently employs 4,861 full-time employees. The firm's main products include Kewei (Oseltamivir Phosphate Capsules and Granules), Ertongshu (Benzbromarone Tablets), Oumeining (Telmisartan Tablets), Linluoxing (Moxifloxacin Hydrochloride Tablets) and Olmesartan Tablets and other products. The firm is also engaged in the centralized procurement business. The firm mainly conducts its business in the domestic market.